From the, No Further Explanation Required files:
The journal Animal Behaviour has retracted a 2009 article by an international group of researchers who, well, did just about everything one could do wrong with a paper.
Here’s the notice, res ipsa loquitur: Continue reading Brown bear, brown bear, what do you see? I see fraud in sexual selection infanticide commentary
Do fraudsters, like bad pitchers or poker players, have “tells”?
Diederik Stapel might. Last week we reported that Stapel, an internationally recognized social psychologist from The Netherlands, had been accused of fabricating his data. An alert Retraction Watch reader has pointed us to a 1999 paper by Stapel with the impossibly ironic title: “Framed and misfortuned: identity salience and the whiff of scandal.”
In the article, which appeared in the European Journal of Social Psychology, Stapel and two colleagues reported the results of survey they’d conducted of Dutch psychologists in the wake of a major plagiarism scandal involving an unidentified Dutch clinical psychologist (“we decided to use neither the name of the person who was accused of plagiarism nor the university to which he was affiliated,” they wrote).
Put briefly, the researchers claimed to have found (rather unsurprisingly) that how psychologists identified themselves professionally dictated how strongly they were affected personally by the scandal. Money quote: Continue reading Did Diederik Stapel tip his pitches in a paper about a plagiarism scandal?
Tilburg University in the Netherlands has suspended the prominent social psychologist Diederik Stapel over concerns that he fabricated data in his published studies. According to a translation of a press release from the school, Stapel, professor of cognitive social psychology and dean of Tilburg’s School of Social and Behavioral Sciences, “has committed a serious breach of scientific integrity by using fictitious data in his publications.”
The release says the rector of Tilburg has set up a committee to investigate Stapel’s manuscripts and report back by October. Heading the panel is W.J.M. Levelt, former* president of the Royal Dutch Academy of Sciences and professor emeritus at the Radboud University in Nijmegen.
What the release does not specify, however, is which of Stapel’s many publications — a Medline search comes up with at least 45 bearing his name — are implicated. Continue reading Dutch university investigating psych researcher Stapel for data fraud
The Journal of Neurochemistry will retract a paper by Jatinder Ahluwalia, the scientist who recently left his post at the University of East London following an investigation into his work.
Ahluwalia was lead author of the 2003 paper, “Activation of capsaicin-sensitive primary sensory neurones induces anandamide production and release,” while earning his PhD at Imperial College London. It had already been the subject of a June 2010 correction. That correction blamed the paper’s problems on a typo: Continue reading Another retraction for Jatinder Ahluwalia, in Journal of Neurochemistry
At least four retractions have appeared involving the work of a group of Japanese researchers who appear to have reused figures — and doctored them — in multiple manuscripts.
The authors, led by Yoshiyuki Hattori, of Dokkyo University School of Medicine in Mibu (whose motto, by the way, is “where character is developed through learning” a reader points out that we had the wrong Dokkyo initially), published the same figure twice, and in the same year, in the Journal of Cardiovascular Pharmacology and Biochimica et Biophysica Acta.
Here’s a retraction notice from the JCP: Continue reading New retractions of diabetes, cardiovascular papers from Japan involve repeat use of figures
The U.S. Department of Health and Human Services’ Office of Research Integrity (ORI) has found that a Boston University cancer researcher made up experiments reported in two papers funded by National Cancer Institute and National Institutes of Health grants. According to the ORI notice:
Sheng Wang, PhD, Boston University School of Medicine Cancer Research Center: Based on the Respondent’s acceptance of ORI’s research misconduct findings, ORI found that Dr. Sheng Wang, who has been an Assistant Professor, Department of Medicine, Boston University School of Medicine Cancer Research Center (BUSM), engaged in research misconduct in research supported by National Cancer Institute (NCI), National Institutes of Health (NIH), grants R01 CA102940 and R01 CA101992.
The two papers were: Continue reading Two papers to be retracted after ORI finds misconduct by Boston University cancer researcher
Genes & Development (G&D) — a journal published by Cold Spring Harbor Laboratory that published only its second retraction in its 24-year history a few weeks ago, has published another. The study, “PRMT1-mediated arginine methylation of PIAS1 regulates STAT1 signaling,” was published in 2009 and has been cited 22 times, according to Thomson Scientific’s Web of Knowledge.
The retraction notice places the blame squarely on first author Susanne Weber, who was a graduate student at the time the study was published and signed the retraction. The G&D notice, in the July 1, 2011 issue, reads: Continue reading Another G&D paper retracted, this one for faked data
The journal Blood has two retractions this month, one of which seems particularly interesting. So let’s deal with the other one first.
The paper, “MicroRNAs 15a/16-1 function as tumor suppressor genes in multiple myeloma,” appeared online in October 2010. But according to the retraction notice, the authors
have recently discovered that the cell lines used in their paper were inadvertently misidentified. The cell lines utilized in the paper have now been found to contain the bcr/abl translocation and most likely represent the K562 CML cell line, instead of MMS1 and RPM1 myeloma cell lines. Due to this issue, the relevance of the findings to myeloma and thus, the conclusions of the paper, are not supported by the data. The authors apologize to the readers, reviewers, and editors of Blood for publishing these erroneous data.
That seems straightforward enough, and we couldn’t find any evidence that this problem affected other publications.
The second paper, however, could be more significant. Continue reading Blood retracts two, including a disputed paper from the Karolinska Institute
An investigation by Emory University in Atlanta has led to the retractions of three articles containing falsified data, but the ambiguous wording of the notices leaves us wondering if they are implying more than they state.
Two of the papers appeared in the journal Arteriosclerosis, Thrombosis, and Vascular Biology. The notices in ATVB implicate a researcher named Lian Zuo, who worked in Emory’s division of cardiology.
Here’s one: Continue reading Data fraud at Emory leads to retractions of three cardiology papers
About a year ago, Acta Crystallographica Section E issued a bombshell editorial. The journal was pulling 70 papers from two groups of researchers at the same Chinese university after discovering that the structures they reported had been fakes.
As the editorial explained, the fraud was detected during a routine review of the structures by Ton Spek, of Utrecht University in The Netherlands. According to the editorial: Continue reading Crystal myth: 11 more retractions from crystallography journal after 2010 fakery